Hormonal contraception
174 results
101 - 174
Oral contraceptives in the treatment of endometriosis - Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
- Oral contraceptives and the risk of ovarian cancer
Levonorgestrel is ineffective emergency contraception for obese women- Progestins for symptomatic treatment of endometriosis
- Sterilization
- Abnormal menstrual bleeding
- Intrauterine device
- Risk of ischaemic stroke in people with migraine with aura
- Dysmenorrhoea
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.- Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception
- Acne
- Combination contraceptives: effects on weight
- Progestin intrauterine devices versus copper intrauterine devices for emergency contraception
- Secondary hypertension
- Continuous or extended cycle use of combined oral contraceptives
- Contraception: initiation, choice of method and follow-up
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Steroid hormones for contraception in men: Cochrane systematic review
- Oestrogens and progestins for preventing and treating postpartum depression: Cochrane systematic review
- Behavioral interventions for improving dual-method contraceptive use: Cochrane systematic review
- Skin problems in people with dark skin
- Triphasic versus monophasic oral contraceptives for contraception: Cochrane systematic review
- Breast cancer and hormonal contraceptives
- OC use associated with reduction in ovarian cancer risk
- Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception
- Progestin‐only contraceptives: effects on weight
- Risk of myocardial infarction in users of third generation oral contraceptives
- Oral contraceptives for pain associated with endometriosis
- Combination injectable contraceptives for contraception
- Prevention of venous thromboembolism
- Steroidal contraceptives and bone fractures in women: evidence from observational studies
- School‐based interventions for improving contraceptive use in adolescents
- Theory‐based interventions for contraception
- Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
- Combined oral contraceptives for heavy menstrual bleeding
- Topiramate for the prophylaxis of episodic migraine in adults
- Saffron promising for treatment of PMS
- Subdermal implants for contraception
- Endometriosis
- Combined hormonal contraceptives for heavy menstrual bleeding
- Benign gynaecological lesions and tumours
- Adverse effects of antineoplastic agents
- Combination contraceptives: effects on weight: Cochrane systematic review
- Vulvovaginitis
- Amenorrhoea
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta‐analysis
- AHA/ACC guideline for the primary prevention of stroke
- Risk of venous thromboembolism in users of combined contraceptives
- Antenatal clinics: care and examinations
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids
- Skin colour changes and pigmentary disorders
- Long acting progestin contraceptives and bone mineral density
- Interventions for hirsutism (excluding laser and photoepilation therapy alone)
- Combined oral contraceptives and bone mineral density